சராசரி பரிவர்த்தனை ப்ரைஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Consultation results On March 17, 2021 the Patented Medicine Prices Review Board (PMPRB) announced the result of the Consultation opened in January (reported here) regarding the definition of “Gap Medicine” and compliance timelines for Grandfathered and Gap Medicines. As proposed, the Guidelines will be amended such that a Gap Medicine will be defined as a medicine for which a Drug Identification Number (DIN) was assigned on or after August 21, 2019, and which was first sold in Canada by July 1, 2021. The PMPRB also clarified that a DIN must have been assigned to the medicine on or after August 21, 2019 but prior to July 1, 2021. The PMPRB will similarly proceed with its proposed revision to the compliance timeline for Grandfathered and Gap Medicines, such that

Patented medicine prices review boardGap medicineDrug identification numberGap medicinesMaximum list priceFederal courtsAverage transaction priceகாப்புரிமை பெற்றது மருந்து ப்ரைஸஸ் விமர்சனம் பலகைஇடைவெளி மருந்துமருந்து அடையாளம் எண்இடைவெளி மருந்துகள்அதிகபட்சம் பட்டியல் ப்ரைஸ்கூட்டாட்சியின் நீதிமன்றங்கள்சராசரி பரிவர்த்தனை ப்ரைஸ்